Skip to content
Esta página está disponible en españolCambiar →

Bellevue Group portfolio

Type not verified

Portfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Aug 14, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗

A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.

Bellevue Group reported a $4.8 bn portfolio of 148 positions to the SEC as of the end of Q2 2026. Its largest positions are AMGN, VRTX, ARGX.

Stock portfolio
$4.8 bn
Positions
148
Top 10: 43%
Turnover
25%
Copying its 13F, 5 years
—
Not calculated: not counted as a concentrated manager

Sections with a free account

What it reported after the quarter end (Q2 2026)

The 13F shows the portfolio as of Jun 30, 2026. Since then Bellevue Group has filed these own trades with the SEC (Form 4, when it owns more than 10% of a company or holds a role in it) and stakes above 5% (13D and 13G). It is not everything it did: only what it must report before the next 13F.

  • 13GYarrow Bioscience10.6 %

    Stake reported in the company · event of Sep 10, 2026 · filed Oct 7, 2026 · filing ↗

  • 13G/AJade BiosciencesJBIO6.8 % → 5 %

    Stake reported in the company · event of Jun 30, 2026 · filed Aug 14, 2026 · filing ↗

What changed this quarter

134 positions with a change (10 new, 38 added to, 64 trimmed, 22 sold); also, 7 entered through an IPO, 2 exited through an acquisition or merger. 12 are listed here: those of 0.5 points of the portfolio or more (up to 12).

It started trading this quarter: it appears in a 13F for the first time. The filing does not say whether the manager already held it before the listing, so it is not counted as a purchase.

The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.

Top holdings

Portfolio by sector

  • ● Health Care 100%

Stakes above 5% (13D/13G)

Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.

How we classify it

Type not verified: we have not assigned a type because we found no document that is enough to tell. Most 13F filers are in this situation: we only review in depth those that meet the portfolio criteria.

Not counted as a concentrated manager: its portfolio is not within 5 to 100 positions; its top 10 positions are under 45%. Its portfolio is shown all the same, but it is left out of manager counts, the consensus and the ranking. How this is decided

Managers of a similar size

A 13F portfolio value between a third and three times this one, whatever the type of filer. It is not a comparison of what they hold.

Follow Bellevue Group for free

When the next 13F is filed, we email you (if you turn it on) and it shows in your list. No credit card.

Follow Bellevue Group